Few cytokines were investigated for diagnostic performance in discriminating PDAC patients from those with other pancreatic diseases and/or healthy individuals (Table 5), some of which were compared to CA19-9 and CEA [45, 46, 52]. This evidence concerns the gene CEACAM5 and pancreas disorder.